Santosh Kesari

35.5k total citations · 5 hit papers
440 papers, 18.1k citations indexed

About

Santosh Kesari is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Santosh Kesari has authored 440 papers receiving a total of 18.1k indexed citations (citations by other indexed papers that have themselves been cited), including 194 papers in Genetics, 154 papers in Molecular Biology and 115 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Santosh Kesari's work include Glioma Diagnosis and Treatment (180 papers), Brain Metastases and Treatment (71 papers) and Cancer Genomics and Diagnostics (30 papers). Santosh Kesari is often cited by papers focused on Glioma Diagnosis and Treatment (180 papers), Brain Metastases and Treatment (71 papers) and Cancer Genomics and Diagnostics (30 papers). Santosh Kesari collaborates with scholars based in United States, China and Canada. Santosh Kesari's co-authors include Patrick Y. Wen, Jan Drappatz, Milan Makale, Sandra Pastorino, Thomas Würdinger, Anna M. Krichevsky, Christine Esau, Galina Gabriely, Carrie R. McDonald and Charles D. Stiles and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Santosh Kesari

413 papers receiving 17.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Malignant Gliomas in Adults

2008 3.3k citations Patrick Y. Wen, Santosh Kesari profile →
MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators

2008 713 citations Galina Gabriely, Thomas Würdinger et al. profile →
Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours

2016 361 citations Carrie R. McDonald, Jona A. Hattangadi‐Gluth et al. profile →
<p>Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives</p>

2019 357 citations Santosh Kesari et al. profile →
A Review of Persistent Post-COVID Syndrome (PPCS)

2021 269 citations Santosh Kesari et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Santosh Kesari United States	63	7.6k	5.9k	4.4k	4.3k	3.0k	440	18.1k
Paul S. Mischel United States	79	10.5k 1.4×	6.0k 1.0×	5.9k 1.4×	4.5k 1.1×	2.2k 0.7×	218	19.5k
Keith L. Ligon United States	72	11.4k 1.5×	7.2k 1.2×	5.2k 1.2×	3.7k 0.9×	2.3k 0.7×	248	21.3k
Howard A. Fine United States	77	9.1k 1.2×	9.6k 1.6×	4.9k 1.1×	5.2k 1.2×	3.8k 1.3×	235	21.3k
Andrew E. Sloan United States	56	4.3k 0.6×	6.1k 1.0×	2.6k 0.6×	4.1k 1.0×	3.5k 1.2×	225	14.0k
Gregory N. Fuller United States	77	8.0k 1.1×	7.1k 1.2×	4.6k 1.0×	5.0k 1.2×	2.9k 0.9×	416	20.2k
Manfred Westphal Germany	65	5.9k 0.8×	8.0k 1.4×	3.6k 0.8×	3.1k 0.7×	2.8k 0.9×	434	18.6k
Ian A. Cree United Kingdom	48	4.7k 0.6×	4.4k 0.7×	3.0k 0.7×	4.9k 1.2×	3.4k 1.1×	230	17.6k
Markus Loeffler Germany	71	4.3k 0.6×	4.2k 0.7×	2.2k 0.5×	5.7k 1.3×	2.3k 0.8×	394	18.6k
Peter Forsyth United States	71	4.8k 0.6×	5.6k 0.9×	2.6k 0.6×	4.4k 1.0×	3.3k 1.1×	251	15.8k
Roger Henriksson Sweden	52	4.8k 0.6×	5.5k 0.9×	2.8k 0.6×	3.5k 0.8×	3.7k 1.2×	405	14.7k

Countries citing papers authored by Santosh Kesari

Since Specialization

Citations

This map shows the geographic impact of Santosh Kesari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Santosh Kesari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Santosh Kesari more than expected).

Fields of papers citing papers by Santosh Kesari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Santosh Kesari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Santosh Kesari. The network helps show where Santosh Kesari may publish in the future.

Co-authorship network of co-authors of Santosh Kesari

This figure shows the co-authorship network connecting the top 25 collaborators of Santosh Kesari. A scholar is included among the top collaborators of Santosh Kesari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Santosh Kesari. Santosh Kesari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hammock, Bruce D., Sung Hee Hwang, Julian P. Whitelegge, et al.. (2025). Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-β clearance underlying vascular complications of Alzheimer's disease. Journal of Alzheimer s Disease. 104(1). 150–157. 3 indexed citations

Khagi, Simon, Jose Carrillo, David Park, et al.. (2025). CTIM-23. FIRST-IN-HUMAN IMMUNOTHERAPY TARGETING LYMPHOPENIA IN RECURRENT GLIOBLASTOMA MULTIFORM (GBM): NAI AND PD-L1 T-HANK PLUS BEVACIZUMAB WITH COMPLETE RESPONSE. Neuro-Oncology. 27(Supplement_5). v119–v119.

Castro, Michael, et al.. (2024). Proton pump inhibitors are detrimental to overall survival of patients with glioblastoma: Results from a nationwide real-world evidence database. Neuro-Oncology Practice. 11(6). 713–722. 1 indexed citations

Lin, Feng, et al.. (2023). Traumatic Brain Injury and Immunological Outcomes: the double-edged Killer. Future Science OA. 9(6). FSO864–FSO864. 6 indexed citations

Park, James H., Adrián López García de Lomana, Diego M. Marzese, et al.. (2021). A Systems Approach to Brain Tumor Treatment. Cancers. 13(13). 3152–3152. 29 indexed citations

Kumthekar, Priya, Shou‐Ching Tang, Andrew Brenner, et al.. (2020). ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases. Clinical Cancer Research. 26(12). 2789–2799. 178 indexed citations

Krishnan, Anitha Priya, Roshan Karunamuni, Kelly M. Leyden, et al.. (2017). Restriction Spectrum Imaging Improves Risk Stratification in Patients with Glioblastoma. American Journal of Neuroradiology. 38(5). 882–889. 13 indexed citations

Schwaederlé, Maria, Barbara A. Parker, Richard B. Schwab, et al.. (2016). Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience. Molecular Cancer Therapeutics. 15(4). 743–752. 125 indexed citations

Schwaederlé, Maria, Hatim Husain, Paul T. Fanta, et al.. (2016). Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients. Clinical Cancer Research. 22(22). 5497–5505. 102 indexed citations

10.

Wang, Xuefeng, Chen Zhang, Xiangming Yan, et al.. (2015). A Novel Bioavailable BH3 Mimetic Efficiently Inhibits Colon Cancer via Cascade Effects of Mitochondria. Clinical Cancer Research. 22(6). 1445–1458. 28 indexed citations

11.

Chakraborty, Sharmistha, Chia‐Ron Yang, Kimmo J. Hatanpaa, et al.. (2013). An EGFR wild type–EGFRvIII–HB-EGF feed-forward loop regulates the activation of EGFRvIII. Oncogene. 33(33). 4253–4264. 35 indexed citations

12.

Shi, Guixin, Rajesh Mukthavaram, Santosh Kesari, & Dmitri Simberg. (2013). Distearoyl Anchor‐Painted Erythrocytes with Prolonged Ligand Retention and Circulation Properties In Vivo. Advanced Healthcare Materials. 3(1). 142–148. 41 indexed citations

13.

Ulmer, S., et al.. (2012). Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma. Neuro-Oncology. 14(4). 482–490. 30 indexed citations

14.

Cho, Jeonghee, Sandra Pastorino, Qing Zeng, et al.. (2011). Glioblastoma-Derived Epidermal Growth Factor Receptor Carboxyl-Terminal Deletion Mutants Are Transforming and Are Sensitive to EGFR-Directed Therapies. Cancer Research. 71(24). 7587–7596. 53 indexed citations

15.

Gabriely, Galina, Ming Yi, Ravi S. Narayan, et al.. (2011). Human Glioma Growth Is Controlled by MicroRNA-10b. Cancer Research. 71(10). 3563–3572. 245 indexed citations

16.

Agnihotri, Sameer, Amparo Wolf, Diana M. Muñoz, et al.. (2011). A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas. The Journal of Experimental Medicine. 208(4). 689–702. 65 indexed citations

17.

Dietrich, Jörg, et al.. (2011). Corticosteroids in brain cancer patients: benefits and pitfalls. Expert Review of Clinical Pharmacology. 4(2). 233–242. 242 indexed citations

18.

Wakimoto, Hiroaki, Santosh Kesari, Christopher J. Farrell, et al.. (2009). Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors. Cancer Research. 69(8). 3472–3481. 279 indexed citations

19.

Schiff, David, et al.. (2008). Cancer Neurology In Clinical Practice. Humana Press eBooks. 14 indexed citations

20.

Kesari, Santosh, et al.. (2005). January 11 Highlight and Commentary. Neurology. 64(1). 1–1. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact